Algo version: 0.98b
Cansino Biologics Inc is listed at the HKSE Exchange
Cansino Biologics Inc [6185.HK]
HKSE Sector: Pharmaceuticals Industry:Drug Manufacturers—Specialty & Generic

Is Cansino Biologics Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Cansino Biologics Inc pays dividends. Last time was Friday 19th of August 2022 where the investors holding the stock on Wednesday 13th of July 2022 were paid HKD0.93727 per share. Over the last 1 times between 2022 and 2022, Cansino Biologics Inc has paid HKD0.93727 with an average of HKD0.94 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Cansino Biologics Inc 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD34.60, you would have made a loss of HKD-16.02 per share or -46.30%

Yes, the average daily trading liquidity for Cansino Biologics Inc is HKD650 457 thousand. You should therefore be able to get in and out of your positions relatively fast.

Cansino Biologics Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Cansino Biologics Inc to be high [0.85 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.